• Nenhum resultado encontrado

[PDF] Top 20 Cytokine profiles during experimental Chagas' disease

Has 10000 "Cytokine profiles during experimental Chagas' disease" found on our website. Below are the top 20 most common "Cytokine profiles during experimental Chagas' disease".

Cytokine profiles during experimental Chagas' disease

Cytokine profiles during experimental Chagas' disease

... the disease process, we have used this murine model (DBA/2 vs ...in cytokine production during the course of infection with ...harvested during the acute phase (day 30) resulted in similarly ... See full document

3

Original article Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern

Original article Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern

... times during in- fection, perhaps by eliminating parasites this restriction is overcome, allowing the innate and adaptive immunity to prog- ress at an optimal ... See full document

11

Different infective forms trigger distinct immune response in experimental Chagas disease.

Different infective forms trigger distinct immune response in experimental Chagas disease.

... parasitemia during all the acute phase of ...proinflammatory cytokine TNF-a and later of IFN-c by both T cells ...this cytokine by IL-10, which provided to these animals an immunomodulatory profile ... See full document

10

In vitro and in vivo experimental models for drug screening and development for Chagas disease

In vitro and in vivo experimental models for drug screening and development for Chagas disease

... evaluated during this procedure and for five days follow- ing the end of the treatment and will be determined based on PCR results negative for parasitaemia (Caldas et ... See full document

6

In vitro and in vivo experimental models for drug screening and development for Chagas disease

In vitro and in vivo experimental models for drug screening and development for Chagas disease

... evaluated during this procedure and for five days follow- ing the end of the treatment and will be determined based on PCR results negative for parasitaemia (Caldas et ... See full document

6

Dendritic cells : a double-edged sword in immune responses during chagas disease

Dendritic cells : a double-edged sword in immune responses during chagas disease

... proinflammatory cytokine production is a MyD88-dependent induction and the expression of IFN- β is a ...achieved during TLR3/TLR7/TLR9-deficient mice ... See full document

12

REPOSITORIO INSTITUCIONAL DA UFOP: Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.

REPOSITORIO INSTITUCIONAL DA UFOP: Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.

... tory disease course and the typical regulatory immune ...in experimental and human studies (Leon et ...flammatory cytokine synthesis, a reduction in ventricu- lar remodelling and an improvement in ... See full document

9

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease

... parasitemia during all the acute phase of ...proinflammatory cytokine TNF-a and later of IFN-c by both T cells ...this cytokine by IL-10, which provided to these animals an immunomodulatory profile ... See full document

10

Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease

Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease

... 2006). Other evidence of this phenomenon is based on the partial blockage of the CC-chemokine receptor inhibitor (Met-RANTES), which induces a reduction in the leuko- cyte influx (modulated by T. cruzi), followed by a ... See full document

9

Analysis of Toll-Like Receptors, iNOS and Cytokine Profiles in Patients with Pulmonary Tuberculosis during Anti-Tuberculosis Treatment

Analysis of Toll-Like Receptors, iNOS and Cytokine Profiles in Patients with Pulmonary Tuberculosis during Anti-Tuberculosis Treatment

... TB disease, autoimmune disease or other infectious ...granulomatous disease, autoimmune disease, cancer, HIV or other immunodeficiency or multidrug resistance and pregnant women were ... See full document

10

BenznidazoleItraconazole Combination Treatment Enhances Anti- Trypanosoma cruzi Activity in Experimental Chagas Disease

BenznidazoleItraconazole Combination Treatment Enhances Anti- Trypanosoma cruzi Activity in Experimental Chagas Disease

... treat Chagas disease; however, they have limitations, including long treatment courses and ...target profiles, re-dosing regimens for the current drugs, drug repositioning and combination ...chronic ... See full document

12

Cytokine and antibody production during murine leptospirosis

Cytokine and antibody production during murine leptospirosis

... leptospirosis during an experimental infection of BALB/c mice inoculated with Leptospira interrogans serovar Canicola was ...that during leptospirosis there was a greater mobilization of the cellular ... See full document

9

Ticks, ivermectin, and experimental Chagas disease

Ticks, ivermectin, and experimental Chagas disease

... examination during the first three weeks of in- fection, with similar levels of parasitaemia to those ob- served in untreated dogs during other periods of the long- term study (see Machado et ... See full document

4

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

... Chagasdisease, caused by the protozoan Trypanosoma cruzi, is a serious health problem in Latin America, where it affects 16 million to 18 million people ...the disease in humans, clinical signs are ... See full document

8

Cytokine production profile of heart-infiltrating T cells in Chagas’ disease cardiomyopathy

Cytokine production profile of heart-infiltrating T cells in Chagas’ disease cardiomyopathy

... chronic Chagas’ disease cardiomyopathy (CCC) is the finding of a T cell-rich inflammatory mononuclear cell infiltrate in the presence of extremely few parasites in the heart ...human Chagas’ ... See full document

5

Incidence of Trypanosoma cruzi transmission through breastfeeding during acute experimental Chagas disease

Incidence of Trypanosoma cruzi transmission through breastfeeding during acute experimental Chagas disease

... After control of vector transmission and blood transfusion, the oral route became the most important and frequent means of transmission of Chagas disease to humans. 4 Besides this route, other less common ... See full document

3

Experimental and clinical treatment of Chagas disease : a review.

Experimental and clinical treatment of Chagas disease : a review.

... Abstract. Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi that infects a broad range of triatomines and mammalian species, including ...mainly during the chronic phase, in ... See full document

15

Chagas disease in Andean countries

Chagas disease in Andean countries

... The progress of control activities for the vector species present in the Andean sub-region, for different reasons, has been slow and control interventions have still not been installed in all geographical areas occu- ... See full document

10

Congenital Chagas disease: an update

Congenital Chagas disease: an update

... Congenital transmission of T. cruzi is a global prob- lem, occurring on average in 5% of children born from chronically infected mothers in endemic areas, with variations depending on the region. Since the diagnosis ... See full document

6

Paleoparasitology of Chagas disease - A Review

Paleoparasitology of Chagas disease - A Review

... Guhl et al. (1997, 1999) began molecular studies in mummies from the Atacama Desert in Northern Chile. They were able to isolate T. cruzi DNA from mummi- fied tissues dating to 4,000 years BP. Less than a month apart, ... See full document

8

Show all 10000 documents...